Now I have a thorough understanding of the paper and calibration anchors. Let me synthesize the final review.

**Calibration comparison:**
- **RegFlow** (6.67): Similar domain (NF-based BGs), new training objective. Solid but simpler theory, good experiments. CMT has richer theory and more systems tested.
- **Diffusion+CV** (6.50): Novel combination of diffusion samplers + CVs. Integration-focused, limited ML novelty. CMT has stronger theoretical contribution.
- **Accelerated PT** (4.00): Mixed reviews, incomplete comparisons. CMT clearly stronger.
- **EWFM** (2.50): Limited novelty, scalability concerns. CMT much stronger.
- **MintJulep** (3.00): Limited experiments, writing issues. CMT much stronger.

CMT sits clearly in the 6.5–7.5 range — strong theory, comprehensive experiments, minor but real limitations.

---

## Summary

This paper introduces Constrained Mass Transport (CMT), a variational framework that constructs intermediate distributions along an annealing path by solving a sequence of problems with trust-region (KL) and entropy-decay constraints. The framework yields analytical forms for intermediates (Propositions 2.1–2.3) and establishes a clean theoretical connection to geometric, tempered, and geometric-tempered annealing paths (Theorem 2.4). The method is instantiated with normalizing flows trained via importance-weighted forward KL and evaluated on molecular Boltzmann generator benchmarks up to the newly introduced ELIL tetrapeptide (d=219). CMT consistently outperforms FAB and TA-BG on sample quality and mode coverage metrics.

## Strengths

- **Principled theoretical framework tying constrained optimization to annealing paths**: Propositions 2.1–2.3 and Theorem 2.4 rigorously derive that trust-region, entropy, and combined constraints yield geometric, tempered, and geometric-tempered annealing paths respectively. This moves beyond heuristic schedule design and provides an interpretable, adaptive schedule.

- **Strong empirical results across four molecular systems of increasing complexity**: Table 1 shows CMT consistently surpasses FAB and TA-BG on EUBO, ESS, and Ramachandran TV distance. Gains are modest on alanine dipeptide but widen substantially on alanine hexapeptide and ELIL tetrapeptide (e.g., ESS of 29.63% vs. 18.22% for TA-BG on alanine hexapeptide; 7.21% vs. 1.26% on ELIL).

- **Convincing ablation demonstrating both constraints are necessary**: Table 3 (Appendix B) and Figures 2–3 show that removing either constraint leads to mode collapse on alanine hexapeptide. The trust-region-only variant achieves competitive metrics but exhibits visible mode collapse in Ramachandran plots (marked with ⋆ in Figure 2d). Only the combined geometric-tempered variant avoids mode collapse while maintaining high ESS. The ablation covers three systems (alanine dipeptide, tetrapeptide, hexapeptide), not just one.

- **Adaptive Lagrangian multiplier tuning with negligible overhead**: The dual optimization (Equation 11) automatically determines the annealing pace using Monte Carlo estimates from already-drawn samples. This removes manual schedule tuning and accounts for only ~0.01% of total training time (Appendix D.4).

- **Introduction of the ELIL tetrapeptide benchmark**: At d=219 with complex side-chain interactions, ELIL is the largest and most challenging system studied to date in the purely energy-based Boltzmann generator setting, providing a valuable stress test where performance gaps between methods are most pronounced.

- **Trust-region provides an approximate, dimension-independent bound on inter-step ESS**: Appendix C.3 analytically derives ESS(q_i, q_{i+1}) ≳ 1/(1 + 2ε_tr), explaining why importance-weighted training remains stable across dimensions. This is supported empirically in Figure 6.

## Weaknesses

### Fatal
None.

### Major
None.

### Minor

- **No statistical significance testing for pairwise comparisons**: Several reported metrics, particularly on smaller systems (e.g., CMT EUBO −175.00 ± 0.00 vs. TA-BG −174.99 ± 0.00 on alanine dipeptide), show differences that are small relative to standard errors. Bold-facing the best value without significance tests overstates confidence on systems where margins are narrow. This does not undermine the overall trend (gains on larger systems are clearly meaningful), but weakens the claim that CMT "consistently surpasses" baselines across all systems and metrics.

- **Trust-region-only CMT not compared against TA-BG/FAB in main results**: The ablation study (Table 3, Appendix B) compares CMT variants to each other across three systems but does not place the trust-region-only variant alongside TA-BG and FAB in the main evaluation. While the ablation does show that trust-region-only suffers from mode collapse on alanine hexapeptide (Figure 3), directly reporting trust-region-only vs. TA-BG would more cleanly isolate whether the adaptive schedule or the entropy constraint drives the gains. The existing ablation already demonstrates that both constraints are needed on the systems tested, so this is a completeness issue rather than a threat to the core claim.

### Trivial

- The abstract claims "more than 2.5× higher effective sample size" without specifying which system or baseline pair this factor corresponds to. The factor is present in the data (e.g., CMT vs. FAB or reverse KL on ELIL tetrapeptide) but should be anchored to a concrete entry.

## Nice-to-Haves

- Quantifying mass teleportation directly (e.g., tracking fraction of mass shifting to near-zero-density regions of the previous intermediate) would provide more direct evidence for the paper's motivating narrative about entropy constraints mitigating mass teleportation. The current evidence is indirect (mode collapse / Ramachandran plots).

- Reporting quantitative results for the non-adaptive schedule experiments described in Appendix B (constant multiplier and TA-BG with more steps) as a short table rather than qualitative descriptions would strengthen the adaptivity claim.

- Ramachandran plots for the trust-region-only variant on systems beyond alanine hexapeptide would give a fuller visual picture of where and why the entropy constraint matters.

- Systematic re-tuning of TA-BG's temperature schedule under the increased computational budget would further bolster the fairness of the comparison, though the authors did increase TA-BG's total target evaluations and gradient steps to match CMT, and TA-BG already uses geometric temperature sequences tuned per system (Appendix D.5, Tables 12–13).

## Removed Points

These points are flagged to be removed; treat them with caution.

- **"Ablation only on a single system"**: The harsh critic claimed the ablation study on constraints is presented "only on a single system." This is incorrect — Table 3 in Appendix B reports the ablation across three systems (alanine dipeptide, tetrapeptide, hexapeptide). The Ramachandran visualizations (Figures 2–3) focus on alanine hexapeptide, but the quantitative ablation is broader. Removed as factually wrong.

- **"Non-adaptive schedule experiments — no numerical results are reported"**: The harsh critic claimed these experiments are "described qualitatively but no numerical results are reported." While it is true that the results are qualitative, the paper explicitly describes the outcomes ("performs significantly worse," "training becomes unstable and exhibits substantial mode collapse"). This is a reasonable but mild presentation limitation, not an evidential gap severe enough to list as a standalone weakness. Moved to Nice-to-Haves.

- **Formatting/style concerns about ESS comparison between CMT and reverse KL**: The harsh critic noted that the paper qualifies ESS for reverse KL but not for CMT vs. FAB/TA-BG. The paper states that ESS values for reverse KL are excluded from the bold-faced comparison because reverse KL suffers from mode collapse, making ESS misleading. This concern about CMT vs. FAB/TA-BG ESS comparison is not actually raised in the paper — the paper explicitly notes "Reverse KL is prone to mode collapse, which makes ESS values not directly comparable" (Table 1 caption). All other methods are trained without mode collapse on the evaluated systems, so the distinction is appropriate. Removed as a strawman.

- **Formatting nitpicks about Slater condition mention**: The harsh critic suggested the paper "could mention the necessary Slater condition more explicitly in the main text." This is a pure presentation nitpick about an appendix-deferred detail. Removed.

- **Missing ablation demand for ESS bound testing**: The harsh critic suggested the trust-region importance-weight variance bound "should be tested more thoroughly in the experiments." The paper does test this in Figure 6 (Appendix B) across different system sizes and trust-region bounds. Removed as already addressed.

- **"The paper does not analyse why ELIL is harder than alanine oligopeptides beyond higher dimensionality"**: The paper states ELIL "contains more complex side chain interactions compared to the alanine hexapeptide" (Section 5.1). This is an explicit explanation. Removed as already addressed.

## Novel Insights

The paper establishes a clean formal equivalence between sequences of constrained variational optimization problems (trust-region, entropy, and their combination) and specific annealing path families (geometric, tempered, geometric-tempered). This connection — while building on known ideas from RL trust-region methods and entropy regularization — provides a unified variational interpretation of annealing that had not been articulated before. The insight that entropy-constrained optimization yields a tempered path (Proposition 2.2, Theorem 2.4), distinct from geometric annealing, and that combining both constraints yields a geometric-tempered path that inherits the strengths of both (overlap preservation from trust-region, mode-collapse prevention from entropy decay control), is genuinely novel and well-supported.

## Suggestions

- Add a column for the trust-region-only CMT variant in Table 1 (or at minimum report its TA-BG/FAB comparison on the largest system) to fully isolate the entropy constraint's contribution.
- Report confidence intervals or note where pairwise differences are within one standard error on Table 1, particularly for alanine dipeptide where margins are narrow, to avoid overclaiming.
- Anchor the "2.5×" claim in the abstract to a specific system–baseline pair.
- Consider a future version that directly tracks a mass-teleportation metric (overlap fraction between successive intermediates) to quantitatively validate the motivating narrative.

## Score and Decision

**Anchor comparison:**

| Path | Avg Score | Comparison to CMT |
|------|-----------|-------------------|
| `ctdnzPxDI3.md` (RegFlow) | 6.67 | Similar domain. CMT has richer theory (constrained optimization → annealing paths), more systems tested (4 vs. 3), and introduces a new benchmark. CMT slightly stronger. |
| `1bJN1EQByS.md` (Diffusion+CV) | 6.50 | Novel integration but weaker ML contribution. CMT has stronger theoretical depth. Comparable overall. |
| `96fJALwotm.md` (Complexity Analysis) | 5.50 | Theory paper on AIS complexity. Different genre. CMT more empirical. |
| `JAOOOgzVUl.md` (Training Trajectory) | 5.50 | Clever idea but narrower scope. CMT more complete. |
| `CODnlyYUli.md` (Accelerated PT) | 4.00 | Mixed reviews, incomplete comparisons. CMT clearly stronger. |
| `S1JJyWg1VG.md` (Data-to-Energy) | 5.00 | Theoretical bridge paper, different focus. |
| `hHfUwjl3hF.md` (Neural Flow Shortcut) | 3.50 | Scalability/estimation concerns. CMT much stronger. |
| `5Gtd4LOOZx.md` (EWFM) | 2.50 | Limited novelty, scalability concerns. CMT much stronger. |
| `gqIv1sduP3.md` (MintJulep) | 3.00 | Limited experiments, writing issues. CMT much stronger. |
| `tT7CXL3I9C.md` (Tilt Matching) | 3.00 | Different approach, theoretical concerns. CMT much stronger. |

CMT compares favorably to the high-scoring anchors (RegFlow at 6.67, Diffusion+CV at 6.50) — it has stronger theory than both and more comprehensive experiments. The minor limitations (no significance tests, trust-region-only not compared against baselines) are real but do not threaten the core claims. The paper's theoretical contribution is clean and novel, the empirical results are convincing on the larger systems where differences matter most, and the ablation effectively demonstrates both constraints are necessary. 

MY FINAL SCORE: <pineapple>7.0</pineapple>
MY FINAL DECISION: <orange>Accept</orange>